DK4128287T3 - Fremgangsmåde til fremstillingen af produkter til isolering af nukleinsyrer - Google Patents

Fremgangsmåde til fremstillingen af produkter til isolering af nukleinsyrer Download PDF

Info

Publication number
DK4128287T3
DK4128287T3 DK21716732.9T DK21716732T DK4128287T3 DK 4128287 T3 DK4128287 T3 DK 4128287T3 DK 21716732 T DK21716732 T DK 21716732T DK 4128287 T3 DK4128287 T3 DK 4128287T3
Authority
DK
Denmark
Prior art keywords
isolation
procedure
manufacture
products
nucleic acids
Prior art date
Application number
DK21716732.9T
Other languages
English (en)
Inventor
Magnar Bjørås
Per Arne Aas
Sulalit Bandyopadhyay
Sten Even Erlandsen
Lars Hagen
Vegar Ottesen
Anuvansh Sharma
Original Assignee
Lybe Scient As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2004987.0A external-priority patent/GB202004987D0/en
Priority claimed from GBGB2004988.8A external-priority patent/GB202004988D0/en
Priority claimed from GBGB2010567.2A external-priority patent/GB202010567D0/en
Priority claimed from GBGB2010570.6A external-priority patent/GB202010570D0/en
Application filed by Lybe Scient As filed Critical Lybe Scient As
Application granted granted Critical
Publication of DK4128287T3 publication Critical patent/DK4128287T3/da

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/0036Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
    • H01F1/0045Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
    • H01F1/0054Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B22CASTING; POWDER METALLURGY
    • B22FWORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/16Metallic particles coated with a non-metal
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09CTREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C3/00Treatment in general of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling properties
    • C09C3/06Treatment with inorganic compounds
    • C09C3/063Coating
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/1013Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/01Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials
    • H01F1/012Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials adapted for magnetic entropy change by magnetocaloric effect, e.g. used as magnetic refrigerating material
    • H01F1/015Metals or alloys
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F41/00Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties
    • H01F41/14Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties for applying magnetic films to substrates
    • H01F41/16Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties for applying magnetic films to substrates the magnetic material being applied in the form of particles, e.g. by serigraphy, to form thick magnetic films or precursors therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y25/00Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Power Engineering (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Manufacturing & Machinery (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK21716732.9T 2020-04-03 2021-04-01 Fremgangsmåde til fremstillingen af produkter til isolering af nukleinsyrer DK4128287T3 (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NO20200428 2020-04-03
GBGB2004987.0A GB202004987D0 (en) 2020-04-03 2020-04-03 Methods and products for isolating nucleic acids
GBGB2004988.8A GB202004988D0 (en) 2020-04-03 2020-04-03 Methods and products for isolating nucleic acids
NO20200427 2020-04-03
GBGB2010567.2A GB202010567D0 (en) 2020-07-09 2020-07-09 Methods and products for isolating nucleic acids
GBGB2010570.6A GB202010570D0 (en) 2020-07-09 2020-07-09 Methods and products for isolating mucleic acids
PCT/EP2021/058780 WO2021198502A1 (en) 2020-04-03 2021-04-01 Methods and products for isolating nucleic acids

Publications (1)

Publication Number Publication Date
DK4128287T3 true DK4128287T3 (da) 2024-06-10

Family

ID=75396803

Family Applications (1)

Application Number Title Priority Date Filing Date
DK21716732.9T DK4128287T3 (da) 2020-04-03 2021-04-01 Fremgangsmåde til fremstillingen af produkter til isolering af nukleinsyrer

Country Status (6)

Country Link
US (1) US12580106B2 (da)
EP (1) EP4128287B1 (da)
AU (1) AU2021247137B2 (da)
CA (1) CA3179338A1 (da)
DK (1) DK4128287T3 (da)
WO (1) WO2021198502A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118679253A (zh) * 2021-12-28 2024-09-20 南京金斯瑞生物科技有限公司 磁珠及其制备方法与在核酸提取中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883867A (en) 1985-11-01 1989-11-28 Becton, Dickinson And Company Detection of reticulocytes, RNA or DNA
WO1993006482A1 (en) 1991-09-16 1993-04-01 Molecular Probes, Inc. Dimers of unsymmetrical cyanine dyes
US5321130A (en) 1992-02-10 1994-06-14 Molecular Probes, Inc. Unsymmetrical cyanine dyes with a cationic side chain
US5410030A (en) 1993-04-05 1995-04-25 Molecular Probes, Inc. Dimers of unsymmetrical cyanine dyes containing pyridinium moieties
US5658751A (en) 1993-04-13 1997-08-19 Molecular Probes, Inc. Substituted unsymmetrical cyanine dyes with selected permeability
US5436134A (en) 1993-04-13 1995-07-25 Molecular Probes, Inc. Cyclic-substituted unsymmetrical cyanine dyes
EP1985714B1 (en) 1998-03-25 2012-02-29 Olink AB Method and kit for detecting a target molecule employing at least two affinity probes and rolling circle replication of padlock probes
DE60137203D1 (de) * 2000-03-24 2009-02-12 Qiagen Gmbh Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung
US20070015165A1 (en) 2005-07-13 2007-01-18 Sigma-Aldrich Co. Method for the isolation of RNA from biological sources
US8323899B2 (en) 2007-02-01 2012-12-04 Siemens Healthcare Diagnostics Inc. Silica magnetic particles with a high nucleic acid binding capacity
US8557329B2 (en) * 2010-05-06 2013-10-15 International Business Machines Corporation Method for silica encapsulation of magnetic particles
EP2388312A1 (en) 2010-05-17 2011-11-23 Curetis AG Universally applicable lysis buffer and processing methods for the lysis of bodily samples
AU2013240200B2 (en) 2012-03-28 2016-10-20 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for the collection and isolation of nucleic acids from biological specimens
WO2014090838A1 (en) * 2012-12-11 2014-06-19 Qiagen Gmbh Preparation of silica particles
US20160348153A1 (en) 2015-05-29 2016-12-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Extraction and preservation of nucleic acid molecules from pathogens
EP3455354B1 (en) 2016-05-13 2023-07-12 Roche Diagnostics GmbH Protein-based sample collection matrices and devices
FI3568475T3 (fi) 2017-01-16 2023-05-15 Spectrum Solutions L L C Nukleiinihapon säilytysliuos ja käyttömenetelmiä
CN106591297A (zh) 2017-02-28 2017-04-26 解码(上海)生物医药科技有限公司 一种磁珠法核酸提取方法
WO2018223067A1 (en) 2017-06-01 2018-12-06 Theranos Ip Company, Llc Methods and compositions for superparamagnetic particles for nucleic acid extraction
CA3080871C (en) * 2017-10-31 2024-05-28 F. Hoffmann-La Roche Ag Improved magnetic beads comprising a liquid-glass coating and uses thereof in nucleic acid capture or purification
CN108853521A (zh) 2018-07-10 2018-11-23 南京邮电大学 一种大孔有机氧化硅包裹四氧化三铁的纳米颗粒及其制备方法和应用

Also Published As

Publication number Publication date
AU2021247137A1 (en) 2022-11-03
AU2021247137B2 (en) 2023-10-12
CA3179338A1 (en) 2021-10-07
US20230223175A1 (en) 2023-07-13
EP4128287A1 (en) 2023-02-08
EP4128287B1 (en) 2024-05-22
US12580106B2 (en) 2026-03-17
WO2021198502A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
DK4017702T3 (da) Fremgangsmåde og systemer til frembringelse af farmaceutiske produkter gennem fremstilling af tilsætningsstof
PL3746564T3 (pl) Sposób amplifikacji kwasów nukleinowych
EP3890977A4 (en) MODIFIED LOADS FOR ADDITIVE MANUFACTURING OF GLASS
DK3139133T3 (da) Indretning og fremgangsmåde til rumlig bestemt måling af temperatur og/eller udstrækning under anvendelse af brillouin-spredning
IL280772A (en) Multiplex detection of nucleic acids
DK3287523T3 (da) Fremgangsmåde til sekretorisk fremstilling af protein
DK3292210T3 (da) Semikontinuerlig fremgangsmåde til fremstilling af rhamnolipider med højt udbytte og høj titer
IL281641A (en) Methods and uses of variant cd80 fusion proteins and related constructs
ES2837136R1 (es) Proceso para la preparación de 3alfa-hidroxi-5alfa-pregnan-20-ona (Brexanolona)
IL282114A (en) Processes for preparing functionalized cyclooctenes
DK3481811T3 (da) Industriel fremgangsmåde til forberedelse af cariprazin
DK3652149T3 (da) Fremgangsmåde til fremstilling af langkædede syrer og dibasiske syrer
DK3328810T3 (da) Tilblanding til fremstilling af infrastrukturelle og strukturelle produkter og tilhørende fremstillingsfremgangsmåde
DK3251523T3 (da) Fremgangsmåde til fremstilling af granuleret tilskudsfoder
DK3880641T3 (da) Fremgangsmåde til fremstilling af glycerider af hydroxycarboxylsyrer
DK3495339T3 (da) Fremgangsmåde til fremstilling af reaktionsprodukt
DK3524063T3 (da) Fremgangsmåde til fremstilling af nukleinsyrekrydderi
EP3872096A4 (en) PROCESS FOR THE SECRETORY PRODUCTION OF A PROTEIN
IL286078A (en) Process for the preparation of lipidated proteinaceous structures
DK4128287T3 (da) Fremgangsmåde til fremstillingen af produkter til isolering af nukleinsyrer
DK3953141T3 (da) Fremgangsmåde til termoformning af polybutylenterephthalat
DK4097117T3 (da) Fremgangsmåde til fremstilling af nukleinsyreoligomer
DK3620452T3 (da) Fremgangsmåde til fremstilling af lenvatinib
DK3737678T3 (da) Fremgangsmåde til fremstilling af disubstituerede diaryloxybenzoheterodiazolforbindelser
EP3611178A4 (en) LIPID DERIVATIVE FOR INTRODUCTION OF NUCLEIC ACID